Article Details
Retrieved on: 2025-09-22 04:59:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dupixent, which was invented using Regeneron's proprietary VelocImmune® technology, is a fully human monoclonal antibody that inhibits the signaling ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here